PerspectivesTherapeutic Options for Recurrent High-Grade Gliomas: A Perspective Statement
References (21)
- et al.
The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma
World Neurosurg
(2011) - et al.
Therapeutic options in recurrent glioblastoma–An update
Crit Rev Oncol Hematol
(2016) - et al.
Therapy for recurrent high-grade gliomas: results of a prospective multicenter study on health-related quality of life
World Neurosurg
(2017) - et al.
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Acta Neuropathol
(2016) - et al.
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
N Engl J Med
(2005) - et al.
Outcome and toxicity profile of salvage low-dose-rate iodine-125 stereotactic brachytherapy in recurrent high-grade gliomas
Acta Neurochir (Wien)
(2015) - et al.
Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection
Neuro Oncol
(2016) - et al.
A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma
Neuro Oncol
(2013) - et al.
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
N Engl J Med
(2015) - et al.
Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial
JAMA
(2015)
There are more references available in the full text version of this article.
Cited by (0)
Commentary on: Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life by Stöckelmaier et al. World Neurosurg 102:383-399, 2017
© 2017 Elsevier Inc. All rights reserved.